Division Inflammatory Stress in Stem Cells, German Cancer Research Center (DKFZ), Heidelberg, Germany; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGMBH), Heidelberg, Germany; Faculty of Biosciences, University of Heidelberg, Heidelberg, Germany.
Program in Translational Biology and Molecular Medicine, Graduate School of Biomedical Sciences, Baylor College of Medicine, Houston, TX.
Exp Hematol. 2021 Apr;96:1-12. doi: 10.1016/j.exphem.2021.02.002. Epub 2021 Feb 8.
Interferons are an ancient and well-conserved group of inflammatory cytokines most famous for their role in viral immunity. A decade ago, we discovered that interferons also play an important role in the biology of hematopoietic stem cells (HSCs), which are responsible for lifelong blood production. Though we have learned a great deal about the role of interferons on HSC quiescence, differentiation, and self-renewal, there remains some controversy regarding how interferons impact these stem cells, with differing conclusions depending on experimental models and clinical context. Here, we review the contradictory roles of Type 1 and 2 interferons in hematopoiesis. Specifically, we highlight the roles of interferons in embryonic and adult hematopoiesis, along with short-term and long-term adaptive and maladaptive responses to inflammation. We discuss experimental challenges in the study of these powerful yet short-lived cytokines and strategies to address those challenges. We further review the contribution by interferons to disease states including bone marrow failure and aplastic anemia as well as their therapeutic use to treat myeloproliferative neoplasms and viral infections, including SARS-CoV2. Understanding the opposing effects of interferons on hematopoiesis will elucidate immune responses and bone marrow failure syndromes, and future therapeutic approaches for patients undergoing HSC transplantation or fighting infectious diseases and cancer.
干扰素是一组古老而保守的炎症细胞因子,因其在抗病毒免疫中的作用而闻名。十年前,我们发现干扰素在造血干细胞(HSCs)的生物学中也起着重要作用,HSCs 负责终生的血液生成。尽管我们已经了解了干扰素对 HSC 静止、分化和自我更新的作用,但关于干扰素如何影响这些干细胞仍存在一些争议,具体取决于实验模型和临床背景,得出的结论也不同。在这里,我们回顾了 1 型和 2 型干扰素在造血中的矛盾作用。具体来说,我们强调了干扰素在胚胎和成人造血、短期和长期适应性以及对炎症的不适应性反应中的作用。我们讨论了研究这些强大但短暂的细胞因子时所面临的实验挑战,以及解决这些挑战的策略。我们进一步回顾了干扰素对包括骨髓衰竭和再生障碍性贫血在内的疾病状态的贡献,以及它们在治疗骨髓增生性肿瘤和病毒感染(包括 SARS-CoV2)方面的应用。了解干扰素对造血的相反作用将阐明免疫反应和骨髓衰竭综合征,以及接受 HSC 移植或对抗传染病和癌症的患者的未来治疗方法。